About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

GRACE - Study of AGN1 LOEP in Osteopenic and Osteoporotic Patients

NCT05966974·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AgNovos Healthcare, LLC

Age

Any age

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Subject has previously received AGN1 LOEP treatment between September 2019 and November 2022.
Subject has willingness to participate in the study.
Subject can give written informed consent to allow for data collection.

You may not be if

The subject's AGN1 LOEP treatment was previously performed as part of a prior protocoled clinical study.

The record

StatusCompleted

PhaseNo phase

Taking part44

StartedDec 2022

UpdatedAug 1, 2023

Conditions

Where1

Vitaz
Sint-Niklaas, Belgium

Clareo Health | GRACE - Study of AGN1 LOEP in Osteopenic and Osteoporotic Patients